Trastuzumab Active Not Recruiting Phase 2 Trials for Gastroesophageal Junction Cancer / Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02726399Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer